Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
41.17
-0.03 (-0.07%)
At close: Apr 28, 2026, 4:00 PM EDT
41.23
+0.06 (0.15%)
After-hours: Apr 28, 2026, 7:58 PM EDT
Novo Nordisk Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Novo Nordisk stock have an average target of 51, with a low estimate of 41 and a high estimate of 70. The average target predicts an increase of 23.88% from the current stock price of 41.17.
Analyst Consensus: Hold
* Price targets were last updated on Mar 2, 2026.
Analyst Ratings
The average analyst rating for Novo Nordisk stock from 11 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 5 | 5 | 6 | 7 | 7 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $63 → $41 | Strong Buy → Hold | Downgrades | $63 → $41 | -0.41% | Mar 2, 2026 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 24, 2026 |
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 8, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $60 → $54 | Strong Buy | Maintains | $60 → $54 | +31.16% | Nov 28, 2025 |
| BMO Capital | BMO Capital | Hold Maintains $50 → $46 | Hold | Maintains | $50 → $46 | +11.73% | Nov 25, 2025 |
Financial Forecast
Revenue This Year
291.89B
from 309.06B
Decreased by -5.56%
Revenue Next Year
302.70B
from 291.89B
Increased by 3.70%
EPS This Year
21.37
from 23.03
Decreased by -7.20%
EPS Next Year
21.38
from 21.37
Increased by 0.04%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 330.5B | 373.4B | ||||||
| Avg | 291.9B | 302.7B | ||||||
| Low | 265.1B | 257.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 6.9% | 27.9% | ||||||
| Avg | -5.6% | 3.7% | ||||||
| Low | -14.2% | -11.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 26.46 | 26.46 | ||||||
| Avg | 21.37 | 21.38 | ||||||
| Low | 17.16 | 16.57 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 14.9% | 23.8% | ||||||
| Avg | -7.2% | 0.0% | ||||||
| Low | -25.5% | -22.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.